Related Experiment Video

Updated: Aug 24, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Assessing hydroxychloroquine toxicity by the multifocal ERG

Michael N Moschos1, Marilita M Moschos, Michael Apostolopoulos

  • 1Department of Ophthalmology, University of Athens, Greece. mosxos@hellasnet.gr

Insights

The multifocal electroretinogram (mfERG) may detect hydroxychloroquine (HC) retinopathy earlier than the electroretinogram (EOG). mfERG monitoring can aid in managing patients on HC treatment.

Area of Science:

  • Ophthalmology
  • Toxicology
  • Retinal Imaging

Background:

  • Hydroxychloroquine (HC) is widely used for autoimmune conditions.
  • HC retinopathy is a serious ocular toxicity that can lead to vision loss.
  • Early detection of HC retinopathy is crucial for preserving vision.

Purpose of the Study:

  • To evaluate the efficacy of multifocal electroretinogram (mfERG) in detecting hydroxychloroquine (HC) retinopathy.
  • To compare mfERG with electroretinography (EOG) in patients on HC treatment.
  • To assess the potential of mfERG for monitoring HC retinopathy progression and treatment response.

Main Methods:

  • Twenty patients undergoing Plaquenil (HC) treatment were assessed.
  • Ocular toxicity was evaluated using both electroretinography (EOG) and multifocal electroretinography (mfERG).
  • Patients were divided into groups based on EOG results (normal or subnormal).

Main Results:

  • In patients with normal EOG, some showed reduced mfERG responses, indicating early toxicity.
  • In patients with subnormal EOG, most exhibited decreased mfERG responses.
  • Following HC interruption, mfERG and/or EOG showed improvement in several cases, suggesting reversibility.

Conclusions:

  • mfERG appears to be a more sensitive method than EOG for detecting early HC retinopathy.
  • mfERG can serve as a valuable tool for the early detection and follow-up of patients at risk of HC retinopathy.
  • Regular mfERG monitoring may help in timely intervention and management of HC-induced ocular toxicity.